Grassi Investment Management’s Novartis NVS Stock Holding History

Grassi Investment Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-79,946	Closed	-$7.55M	–	145
2020 Q4	$7.55M	Sell	79,946 -8,950	-10%	-$782K	0.96%	42
2020 Q3	$7.73M	Buy	88,896 +325	+0.4%	+$28.2K	1.1%	36
2020 Q2	$7.74M	Buy	88,571 +1,525	+2%	+$132K	1.12%	39
2020 Q1	$7.18M	Buy	87,046 +7,690	+10%	+$686K	1.26%	37
2019 Q4	$7.51M	Buy	79,356 +2,925	+4%	+$262K	1.02%	44
2019 Q3	$6.64M	Buy	76,431 +4,460	+6%	+$400K	1%	47
2019 Q2	$6.57M	Buy	71,971 +67,232	+1,419%	+$5.69M	0.97%	48
2019 Q1	$408K	Buy	+4,739	New	+$380K	0.06%	103

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Grassi Investment Management's NVS Position: Q1 2021 in Review

Grassi Investment Management sold out of Novartis (NVS) in Q1 2021, closing a stake of 79,946 shares — an estimated $7.55M sold.

Grassi Investment Management first reported a position in NVS in Q1 2019 and held it in 8 quarters. The position peaked at $7.74M in Q2 2020. 1,135 funds tracked by Wall St. Rank hold NVS as of Q1 2021.

Grassi Investment Management reported no remaining Novartis position as of Q1 2021 after selling out during the quarter.
Grassi Investment Management sold 79,946 Novartis shares in Q1 2021, an estimated $7.55M.
Grassi Investment Management first reported a position in Novartis in Q1 2019 and held it in 8 quarters.
Grassi Investment Management's Novartis position peaked at $7.74M in Q2 2020.
1,135 funds tracked by Wall St. Rank held Novartis as of Q1 2021.

Based on Grassi Investment Management's 13F filing for Q1 2021, filed 12 Apr 2021.